Fellow's voice: Hypertriglyceridemia: Understanding the current guideline
Open Access
- 22 February 2022
- journal article
- research article
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 9, 100322
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent HypertriglyceridemiaJACC, 2021
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood CholesterolJACC, 2019
- Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaNew England Journal of Medicine, 2019
- A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With HypertriglyceridemiaThe American Journal of Cardiology, 2016
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2Journal of Clinical Lipidology, 2015
- Low Nonfasting Triglycerides and Reduced All-Cause Mortality: A Mendelian Randomization StudyClinical Chemistry, 2014
- Common variants associated with plasma triglycerides and risk for coronary artery diseaseNature Genetics, 2013
- Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarctionEuropean Heart Journal, 2012